Nectero Medical
Manufacturing · Arizona, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
2343 W University Dr Ste D103, Tempe, Ar...Phone Number
(866) 755-4744Website
www.necteromedical.comRevenue
$7 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Nectero Medical
Nectero Medical is a medical technology company developing an endovascular aortic stabilization treatment which reduces the growth rate of aortic aneurysms. The company is based in Tempe, AZ.Explore more
Nectero Medical Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Nectero Medical your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Nectero Medical has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Nectero Medical
Product Launch: Get notified when Nectero Medical launches new products
Check if Nectero Medical has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Nectero Medical recently announced quarterly report
Check out if Nectero Medical is spiking on competitors!
Nectero Medical, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Nectero Medical had a recent Job posting/layoffs
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Nectero Medical
Compare insights from companies similar to Nectero Medical, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Nectero Medical is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Nectero Medical is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Nectero Medical.
Nectero Medical financials insights
Gather financial insights about Nectero Medical, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Series C
$19.5M
2024
Series D
$96M
Nectero Medical Tech Stack
A closer look at the technologies used by Nectero Medical
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Funding
Funding
Executive Move
Jack Miceli has been named Chief Financial Officer.
Project
Product Management, Compliance, Legal Affairs
Nectero Medical News & Media
Nectero Medical Recognized as a 2024 AZBio Fast Lane Award Winner
TEMPE, Ariz., Sept. 24, 2024 (GLOBE NEWSWIRE) -- Nectero Medical, a clinical-stage biotechnology company pioneering novel therapies to treat aneurysmal disease, announced today that it received a 2024 AZBio™ Fast Lane Award from the Arizona Bioindustry Association (AZBio). Each year a select group of Arizona-based life science companies are recognized for the progress they are making to develop and deliver health innovations. Nectero Medical accepted the award at the 20th Annual AZBio Awards DinNectero Medical Announces Completion of $96M Series D Financing
TEMPE, Ariz.--(BUSINESS WIRE)-- #AbdominalAorticAneurysm--Nectero Medical, a clinical-stage biotechnology company pioneering novel therapies to treat aneurysmal disease, today announced the closing of its $96 million Series D financing round. Financing was led by Norwest Venture Partners, with large investments from Boston Scientific Corporation, BioStar Capital, Cadence Healthcare Ventures, Aphelion Capital and other firms. Proceeds will be utilized to accelerate the execution of the Phase II/INectero Medical Announces Initiation of Phase II/III Clinical Trial of the Nectero EAST® System for Treatment of Small- to Medium-Sized Abdominal Aortic Aneurysms
TEMPE, Ariz.--(BUSINESS WIRE)-- #AbdominalAorticAneurysm--Nectero Medical, a clinical-stage biotechnology company pioneering novel therapies to treat aneurysmal disease and improve patients’ lives, today announced initiation of a Phase II/III clinical trial (stAAAble) to investigate the safety and efficacy of the Nectero Endovascular Aneurysm Stabilization Treatment (Nectero EAST®) System in patients with infrarenal abdominal aortic aneurysms (AAAs), maximum diameter 3.5 – 5.0cm. The Nectero EASNectero Medical Granted Breakthrough Therapy Designation for the Nectero EAST® System to Treat Infrarenal AAA
TEMPE, Ariz.--(BUSINESS WIRE)-- #AbdominalAorticAneurysm--Nectero Medical, a clinical-stage biotechnology company pioneering novel therapies to treat aneurysmal disease, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation for the Nectero Endovascular Aneurysm Stabilization Treatment (Nectero EAST®) System to treat patients with infrarenal AAAs, maximum diameter 3.5 – 5.0cm. Nectero Medical is initiating a randomized, controlled Phase II/I
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Nectero Medical
Sign Up For FreeTo access detailed company insights
Nectero Medical is a medical technology company developing an endovascular aortic stabilization treatment which reduces the growth rate of aortic aneurysms. The company is based in Tempe, AZ.... Read More
